Neutrophil to lymphocyte ratio (NLR) as an indicator of tumor immune status in non-small cell lung cancer

被引：0
|
作者：
Yoshichika, Ryo
Iwata, Kazuma
Suzawa, Ken
Thu, Yin Min
Mizuno, Daisuke
Higashihara, Tomoaki
Hayashi, Naohiro
Matsuoka, Atsushi
Yoshikawa, Mao
Mukohara, Fumiaki
Shien, Kazuhiko
Yamamoto, Hiromasa
Toyooka, Shinichi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7667
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7667
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Retrospective study on neutrophil-to-lymphocyte ratio (NLR) as a prognostic biomarker in ALK-positive non-small cell lung cancer (NSCLC)
    Lara Gonzalez, N. G.
    Benitez Fuentes, J. D.
    Diaz Rengifo, I. A.
    Bermejo Martinez, P. P.
    Bach Mora, R.
    Lahoz Hormigos, T.
    Lacalle Gonzalez, C.
    Martin Bravo, C.
    Vargas-Castrillon, E.
    Jimenez Ortega, A. F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 : 64 - 64
  • [22] Relationship between tumor infiltrating lymphocytes (Tils) and neutrophil-lymphocyte ratio (NLR) as a prognostic factor in patients with advanced non-small cell lung cancer.
    Richardet, Eduardo
    Hernandez, Patricia Andrea
    Richardet, Martin Eduardo
    Cortes, Matias Nicolas
    Molina, Matias
    Acosta, Luciana Paola
    Dicalbo, Luciano
    Villavicencio, Rocio
    Pets, Evelin
    Paradelo, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] The prognostic influence of neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in stage III non-small cell lung cancer (NSCLC) treated with consolidation durvalumab.
    Nindra, Udit
    Shahnam, Adel
    Stevens, Samuel Xavier
    Pal, Abhijit
    Yip, Po Yee
    Adam, Tamiem
    Lee, Jenny Hj
    Boyer, Michael J.
    Nagrial, Adnan
    Kao, Steven Chuan-Hao
    Bray, Victoria Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18773 - E18773
  • [24] Neutrophil-to-Lymphocyte Ratio is an Independent Prognostic Indicator for Overall Survival among Patients with Oligometastatic Non-Small Cell Lung Cancer
    Ludmir, E. B.
    Farooqi, A.
    Mitchell, K. G.
    Antonoff, M.
    Gomez, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E517 - E517
  • [25] Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): Neutrophil to lymphocyte ratio (NLR) and the risk for toxicity recurrence
    Pretelli, G.
    Pavan, A.
    Dal Maso, A.
    Resi, M. V.
    Mulargiu, C.
    Ferro, A.
    Benetti, B.
    Lorenzi, M.
    Marinato, G. M.
    Frega, S.
    Pasello, G.
    Conte, P. F.
    Guarneri, V.
    Bonanno, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S61 - S61
  • [26] Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer?
    Yildirim, Fatma Bodur
    Sevimli, Nurgul
    Turk, Murat
    Demirci, Niligun Yilmaz
    Yurdakul, Ahmet Selim
    Ozturk, Can
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [27] The Association of Prechemotherapy Neutrophil-Lymphocyte Ratio With Survival in Non-Small Cell Lung Cancer Patients
    Mangla, A.
    Thekkekara, R.
    Yadav, U.
    Mohajer, R.
    Lad, T.
    Stroger, John H., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S64 - S64
  • [28] PROGNOSTIC VALUE OF NEUTROPHIL TO LYMPHOCYTE RATIO IN NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE COHORT STUDY
    Sekar, Abinesh
    Shaik, Sajid
    Perkit, Navya Reddy
    Singh, Abhishek
    Ramasamy, Chidambaram
    Singh, Yuvaraj
    Seetharaman, Kala
    Abraham, George
    CHEST, 2023, 164 (04) : 4206A - 4206A
  • [29] The Association of Prechemotherapy Neutrophil-Lymphocyte Ratio With Survival in Non-Small Cell Lung Cancer Patients
    Mangla, A.
    Thekkekara, R.
    Yadav, U.
    Mohajer, R.
    Lad, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S670 - S670
  • [30] Neutrophil Lymphocyte Ratio as a Prognostic Factor in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
    Richardet, Eduardo
    Richardet, M.
    Molina, M.
    Magi, I.
    Peruchin, V.
    Perea, P.
    Tello, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S12 - S12
12345